TSMZ

Direxion Daily TSM Bear 1X Shares

$13.10
+0.00%
Market closed. Last update: 10:56 PM ET

📎 Investment Objective

The Direxion Daily TSM Bear 1X Shares ETF (TSMZ) seeks to provide daily investment results that correspond to the inverse (-1x) of the daily performance of the Wilshire 5000 Total Market Index.

Overview

ETF tracking Direxion Daily TSM Bear 1X Shares

Category Inverse
Issuer Other
Inception Date 2024-10-03
Market Cap $2.9M
Average Volume N/A
Dividend Yield 5.09%
52-Week Range $12.23 - $28.37
VWAP $13.35

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The Direxion Daily TSM Bear 1X Shares ETF (TSMZ) seeks to provide daily investment results that correspond to the inverse (-1x) of the daily performance of the Wilshire 5000 Total Market Index.

🎯 Investment Strategy

The fund uses a range of financial instruments, such as swap agreements and futures contracts, to provide inverse exposure to the Wilshire 5000 Total Market Index. It does not seek to achieve its stated investment objective over a period of time greater than one day.

✨ Key Features

  • Inverse exposure to the broad U.S. equity market, as represented by the Wilshire 5000 Total Market Index
  • Designed for short-term, tactical trading rather than long-term buy-and-hold investing
  • Employs derivatives to achieve its inverse performance objective
  • Has a very low expense ratio of 0.00%

⚠️ Primary Risks

  • Inverse performance risk: The fund's returns will be the opposite of the index, amplifying losses when the market rises
  • Derivative risk: The use of swaps and futures contracts introduces additional counterparty and liquidity risks
  • Compounding risk: Daily rebalancing can lead to returns that differ significantly from the index over longer holding periods
  • Lack of track record: The fund has no performance history, making it difficult to evaluate its long-term viability

👤 Best For

This ETF is best suited for experienced, sophisticated investors who have a high risk tolerance and are looking for short-term, tactical exposure to a declining U.S. equity market. It is not recommended for long-term buy-and-hold investors or those with a low risk appetite.